Neuroscience
Business World: Cyberonics and Neurostimulators
The
Houston Press, which is an alternative news weekly in Houston, has a feature article this week about Cyberonics and its epilepsy device and its exploration of applications in mood disorders:
Exposed Nerve Cyberonics has implanted its pacemaker in thousands of epileptics. It wants to expand to the depression market. Still needed: an accounting of those who died or were injured after receiving its implant. BY CRAIG MALISOW
The Houston Press7-13 April 2005
[ ... Read the full article ... ]
-
Rfid In Neurotech
“You have to void yourself of prejudices, pre-conceived ideas or whether you’ve seen this type of person before when it’s time to get to work on something,” said Marlin Mickle. “Because if you don’t, your mind starts to focus on that and you...
-
Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
Tomorrow's New York Times includes an article about the current state of FDA consideration of the Cyberonics VNS device for the treatment of depression. The article is notable for the number of interviews across the spectrum of opinion on this pending...
-
Business World: Cyberonics And Neurostimulators (vagal Nerve Stimulator [vns])
From Reuters: Cyberonics falls as Senate probes FDA turnaround Thu May 19, 2005 10:07 AM ET CHICAGO (Reuters) - Shares of Cyberonics Inc. fell almost 13 percent on Thursday after the Senate Finance Committee began examining the FDA's handling of...
-
Vagal Nerve Stimulator And Depression
From The New York Times:
F.D.A. May Approve an Implant as a Treatment for Depression
By BARNABY J. FEDER
The New York Times
Published: February 4, 2005
The Food and Drug Administration said yesterday that it might permit an implantable electrical...
-
Business World: Neuromodulation
This Canadian National Post report, among many yesterday and today, outlines ANS [company website] and Cyberonics [company website] issues:
Advanced Neuromodulation Systems bids US$22 a share for Cyberonics
Canadian Press (copyright)
Thursday, September...
Neuroscience